Sun Pharma, Cipla already been re-rated a lot: P Phani Sekhar

In a chat with ET Now, P Phani Sekhar, Fund Manager-PMS, Angel Broking shares his view on Sun Pharma, Cipla

ET Now: Just wanted a quick perspective on Sun Pharma and Cipla earnings, do you think the stocks could get re-rated?

P Phani Sekhar: They have already been re-rated a lot so I guess there is little scope at least in the longer term perspective for that to happen but in the very near term since the number of options for investors are lesser, there can be more excitement out there.